Pacira BioSciences, Inc. PCRX Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 79.4%+3.7pp | 75.7%+3.0pp | 72.6%+2.5pp | 70.1%-4.0pp | |
| Operating margin | 2.6%— | —— | 13%— | —— | |
| Net margin | 1%— | —— | 6.2%— | —— | |
| EBITDA margin | 15.2%— | —— | 24.2%— | —— | |
| Free cash flow margin | 18.8%-6.7pp | 25.5%+4.8pp | 20.7%+3.4pp | 17.3%+2.5pp | |
| Returns | |||||
| Return on equity | 1%— | —— | 5.1%— | —— | |
| Return on assets | 0.5%— | —— | 2.6%— | —— | |
| Return on invested capital | 1.9%— | —— | 6.3%— | —— | |
| Efficiency | |||||
| Asset turnover | 0.5×+0.1× | 0.4×0.0× | 0.4×+0.1× | 0.4×0.0× | |
| Inventory turnover | 1.1×-0.4× | 1.5×-0.4× | 1.8×-0.2× | 2×+0.3× | |
| Liquidity | |||||
| Current ratio | 4.5×+2.1× | 2.4×-2.8× | 5.2×+1.9× | 3.4×+1.7× | |
| Quick ratio | 3.3×+1.3× | 2×-2.2× | 4.2×+1.4× | 2.7×+1.2× | |
| Cash ratio | 1.3×+0.4× | 0.9×-0.7× | 1.6×+0.9× | 0.7×-0.4× | |
| Leverage | |||||
| Debt-to-equity | 0.6×-0.1× | 0.7×+0.5× | 0.2×-0.2× | 0.4×-0.6× | |
| Debt-to-assets | 0.3×0.0× | 0.4×+0.2× | 0.1×-0.1× | 0.2×-0.2× | |
| Net debt / EBITDA | 2.4×— | —— | 0.2×— | —— | |
| Interest coverage | 1.1×— | —— | 4.3×— | —— | |
| Per Share | |||||
| Book value per share | $15.39-8.6% | $16.83+0.5% | $16.74+0.5% | $16.65+4.0% | |
| Valuation | |||||
| Market capitalization | $942.78M-14.5% | $869.9M-44.5% | $1.57B-11.6% | $1.77B-33.9% | |
| Enterprise value | $1.21B+2.6% | $1.15B-27.9% | $1.6B-19.6% | $1.99B-30.3% | |
| Price / earnings | 183.5×— | —— | 37.3×— | —— | |
| Price / sales | 1.3×-0.3× | 1.2×-1.1× | 2.3×-0.3× | 2.7×-2.3× | |
| Price / book | 1.5×+0.1× | 1.1×-0.7× | 1.8×-0.5× | 2.3×-1.4× | |
| EV / EBITDA | 10.6×— | —— | 9.8×— | —— | |
| EV / sales | 1.7×0.0× | 1.6×-0.7× | 2.4×-0.6× | 3×-2.3× | |
| Free cash flow yield | 13.8%-0.4pp | 20.5%+11.6pp | 8.9%+2.4pp | 6.5%+3.5pp | |
| Earnings yield | 0.5%— | —— | 2.7%— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pacira BioSciences, Inc.'s profit margins?
- Pacira BioSciences, Inc. (PCRX) runs a 79.3% gross margin and a 3.3% operating margin, with a 0.7% net margin.
- Where do Pacira BioSciences, Inc.'s ratios come from?
- Every ratio is computed from Pacira BioSciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
